News

Argos Therapeutics Presents Transplantation Data for Soluble CD83 Demonstrating its Ability to Induce Immune Tolerance and Suppress Anti-donor Antibody Responses

maio 6, 2010

Human Health

Portfolio

Back

Download

PDF